Professional Role and Background
David Schenkein, MD, currently serves at GV (Google Ventures), a venture capital investment arm of Alphabet Inc. GV is known for investing in technology-driven companies across a range of sectors including healthcare, life sciences, artificial intelligence, and consumer technology. Dr. Schenkein’s medical degree and extensive experience indicate a specialization likely focused on healthcare-related investments within GV’s portfolio.
Relevant Expertise and Industry Focus
His professional profile links clinical insight with venture capital, positioning him as an intersectional expert able to evaluate startups and initiatives with a medical or biotechnological core. This dual competency is particularly relevant when assessing companies in medical devices, diagnostics, pharmaceuticals, or digital health services. Dr. Schenkein likely contributes to deal sourcing, due diligence, and strategic scaling advice for healthcare innovations in GV’s investment pipeline.
Professional Network and Influence
As a senior individual at GV, David Schenkein is connected to a significant network within Silicon Valley’s healthcare venture ecosystem, which includes researchers, entrepreneurs, and senior executives at cutting-edge biotech and health tech companies. His presence on LinkedIn (https://www.linkedin.com/in/david-schenkein-md-45342476/) demonstrates active engagement with professional content and collaborations, which can be valuable for understanding market trends and emerging technologies from a clinical and investment perspective.
Investment Philosophy and Approach
GV’s investment strategy emphasizes disruptive, high-growth potential ventures. Given Dr. Schenkein’s medical credentials combined with venture leadership, his approach likely involves rigorous clinical validation balanced with market scalability and technological innovation. His decisions and evaluations would prioritize startups demonstrating strong clinical data, regulatory pathway viability, and scalable business models in healthcare.
GV’s Recent Activity and Market Position
GV has maintained significant venture activity in healthcare and biotech, with investments spanning early-stage startups to growth companies. The firm’s substantial capital backing and connection to Alphabet’s ecosystem position it to provide portfolio companies with both funding and technological expertise. Dr. Schenkein’s role aligns with supporting this ecosystem by facilitating informed, medically-grounded investment decisions.
This profile indicates that David Schenkein, MD, brings a sophisticated blend of clinical knowledge and venture capital acumen to GV's healthcare investment landscape, enabling him to evaluate complex healthcare innovations and contribute strategically to high-impact portfolio development.
